<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00237978</url>
  </required_header>
  <id_info>
    <org_study_id>TUD-Akne02-003</org_study_id>
    <nct_id>NCT00237978</nct_id>
  </id_info>
  <brief_title>Control of Therapy of Acne Papulopustulosa by Visible Light With Waterfiltered Infrared and / or Adapalen (Differin Gel)</brief_title>
  <official_title>Control of Therapy of Acne Papulopustulosa by Visible Light With Waterfiltered Infrared and / or Adapalen (Differin Gel)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Technische Universität Dresden</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Technische Universität Dresden</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to investigate the effectivity of visible light in combination with
      waterfiltered infrared in treating acne papulopustulosa. The reduction of inflammatory and
      non-inflammatory lesions within 8 weeks will be measured and compared with the standard
      treatment with Adapalene.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2006</start_date>
  <completion_date type="Anticipated">September 2009</completion_date>
  <primary_completion_date type="Anticipated">June 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>reduction of inflammatory and non-inflammatory lesions within 8 weeks after start of therapy</measure>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Acne Papulopustulosa</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>VIS and wIRA</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>VIS, wIRA and Adapalen</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Adapalen</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Adapalen</intervention_name>
    <arm_group_label>2</arm_group_label>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>VIS and wIRA</intervention_name>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Mild to moderate acne papulopustulosa according to Burton Scale Stage 3 to 4

          -  At least 5 inflammatory and 5 non-inflammatory lesions in the face

          -  Age &gt;= 14 years

        Exclusion Criteria:

          -  pregnant and nursing women

          -  Antiandrogen therapy

          -  therapy with antibiotics within the last 4 weeks

          -  therapy with retinoids within the last 6 months

          -  natural or artificial UV-therapy within the last 4 weeks

          -  severe acne papulopustulosa according to Burton Scale 5 or 6

          -  Severe systemic condition

          -  Secondary acne
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roland Aschoff, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Technische Universität Dresden, Fetscher Str. 74, 01307 Dresden, Germany</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Roland Aschoff, MD</last_name>
    <phone>0049-351-458</phone>
    <phone_ext>2007</phone_ext>
    <email>Roland.Aschoff@mailbox.tu-dresden.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden</name>
      <address>
        <city>Dresden</city>
        <state>Sachsen</state>
        <zip>01307</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roland Aschoff, MD</last_name>
      <phone>0049-351-458</phone>
      <phone_ext>2007</phone_ext>
      <email>Roland.Aschoff@mailbox.tu-dresden.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 12, 2005</study_first_submitted>
  <study_first_submitted_qc>October 12, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 13, 2005</study_first_posted>
  <last_update_submitted>May 13, 2009</last_update_submitted>
  <last_update_submitted_qc>May 13, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 14, 2009</last_update_posted>
  <responsible_party>
    <name_title>Roland Aschoff, MD</name_title>
    <organization>Technical University Dresden</organization>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adapalene</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

